Ceapro Inc V.CZO

Proph. the manipulator

[fossi_2002]

Comment by prophetoffactzon Dec 15, 2023 3:57am
lscfa wrote: Nov 13, 2023 — HC Wainwright Cuts Aeterna Zentaris' Price Target to $15 From $28, Maintains Buy Rating

With 4.86 million shares according to Stockhouse US$28 would be a US$138 million market cap. That is similar to what Novo Nordisk put into AEZS's growth hormone deficiency test:

...US$145 million plus tiered royalties and an equity investment worth more than US$36
million...
Proph... is the biggest manipulator on this board. If Wainwright cuts the price target from 28$ to 15$, the market value is just under 73 million, but he talks about 138 million because he simply uses the old price target - it couldn't be worse!

[Ciao]

HC Wainwright is biased as they did the last underwriting with shares at $1.45. Given the 25 for 1 share rollback, it was effectively at $36.25. Shares are at $2.18 for a loss of 96% all in a matter of 3 years. AEZS is a dog, period.  Until recently, CZO had a very high gross margin de-risked base businses, was generating net profit, had positive cash flow, and adding to its cash to fund it

[PBaelishh]

Nothing is de-risked as long as the biggest risk remains: GILLES GAGNON.

[Ciao]

That's been demonstrated with his tenure at AEZS as the CEO where the share price has dropped 80%, and more recently when he joined the board in 2020 where the share price dropped 96% (including a 1 for 25 share rollback) to where it is now. His failures in running CEAPRO have been well documented here. As we are calling the board to remove him from the CEO seat, he is circumventing all this

[Ciao]

The whole SHAM of a merger is summarized above. Worth reading again. Essentially CZO is throwing AEZS a lifeline to maintain a listing on NASDAQ with this whole merger of two equals BS. Takeover CZO, rollback shares about 3X to keep the share price artificially high, then try to raise funds touting PGX.

[prophetoffactz]

AEZS maintains its NASDAQ listing. CZO wants a NASDAQ listing and gets it. Together they will have increased news flow and an increased asset base to attract analysts and other market player. Together the companies can streamline costs: 1) The TSX-V listing will be dropped. 2) They will only need one CFO, Director of Business development, etc., and only need one IR firm, etc. 3) The number of